• 2025
  Kordahi MC, Daniel N, Gewirtz AT, Chassaing B, Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation., Gut Microbes 2025 Dec; 17(1): 2455790.
• 2025
  Rytter H, Naimi S, Wu G, Lewis J, Duquesnoy M, Vigué L, Tenaillon O, Belda E, Vazquez-Gomez M, Touly N, Arnone D, Hao F, Ley RE, Clément K, Peyrin-Biroulet L, Patterson AD, Gewirtz AT, Chassaing B, In vitro microbiota model recapitulates and predicts individualised sensitivity to dietary emulsifier., Gut 2025 Jan; (): .
• 2024
  Jazmin Meza-Torres, Jean-Yves Tinevez, Aline Crouzols, Héloïse Mary, Minhee Kim, Lise Hunault, Susan Chamorro-Rodriguez, Emilie Lejal, Pamela Altamirano-Silva, Déborah Groussard, Samy Gobaa, Johann Peltier, Benoit Chassaing, Bruno Dupuy, Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies, Gut microbes, 2024, 17 (1), pp.2444411. ⟨10.1080/19490976.2024.2444411⟩.
• 2024
  Whelan K, Bancil AS, Lindsay JO, Chassaing B, Ultra-processed foods and food additives in gut health and disease., Nat Rev Gastroenterol Hepatol 2024 Jun; 21(6): 406-427.
• 2024
  Couvert A, Goumy L, Maillard F, Esbrat A, Lanchais K, Saugrain C, Verdier C, Doré E, Chevarin C, Adjtoutah D, Morel C, Pereira B, Martin V, Lancha AH, Barnich N, Chassaing B, Rance M, Boisseau N, Effects of a Cycling versus Running HIIT Program on Fat Mass Loss and Gut Microbiota Composition in Men with Overweight/Obesity., Med Sci Sports Exerc 2024 May; 56(5): 839-850.
• 2024
  Salame C, Javaux G, Sellem L, Viennois E, de Edelenyi FS, Agaësse C, De Sa A, Huybrechts I, Pierre F, Coumoul X, Julia C, Kesse-Guyot E, Allès B, Fezeu LK, Hercberg S, Deschasaux-Tanguy M, Cosson E, Tatulashvili S, Chassaing B, Srour B, Touvier M, Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Santé prospective cohort study., Lancet Diabetes Endocrinol 2024 May; 12(5): 339-349.
• 2024
  Sivapiromrat AK, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt WR, Weinstein S, Jathal I, Alvarez JA, Chassaing B, Ziegler TR, Gewirtz AT, Tangpricha V, Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis., Contemp Clin Trials Commun 2024 Apr; 38(): 101278.
• 2024
  Sellem L, Srour B, Javaux G, Chazelas E, Chassaing B, Viennois E, Debras C, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Arnault N, Agaësse C, De Sa A, Lutchia R, Huybrechts I, Scalbert A, Pierre F, Coumoul X, Julia C, Kesse-Guyot E, Allès B, Galan P, Hercberg S, Deschasaux-Tanguy M, Touvier M, Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort., PLoS Med 2024 Feb; 21(2): e1004338.
• 2024
  Delaroque C, Chassaing B, Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice., NPJ Biofilms Microbiomes 2024 Jan; 10(1): 1.
• 2024
  Bonazzi E, Bretin A, Vigué L, Hao F, Patterson AD, Gewirtz AT, Chassaing B, Individualized microbiotas dictate the impact of dietary fiber on colitis sensitivity., Microbiome 2024 Jan; 12(1): 5.
• 2024
  Langhi C, Vallier M, Bron A, Otero YF, Maura M, Le Joubioux F, Blomberg N, Giera M, Guigas B, Maugard T, Chassaing B, Peltier S, Blanquet-Diot S, Bard JM, Sirvent P, A polyphenol-rich plant extract prevents hypercholesterolemia and modulates gut microbiota in western diet-fed mice., Front Cardiovasc Med 2024 ; 11(): 1342388.
• 2024
  Paudel D, Nair DVT, Tian S, Hao F, Goand UK, Joseph G, Prodes E, Chai Z, Robert CEM, Chassaing B, Patterson AD, Singh V, Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation., Gut Microbes 2024 ; 16(1): 2341457.
• 2024
  Daniel N, Wu GD, Walters W, Compher C, Ni J, Delaroque C, Albenberg L, Ley RE, Patterson AD, Lewis JD, Gewirtz AT, Chassaing B, Human Intestinal Microbiome Determines Individualized Inflammatory Response to Dietary Emulsifier Carboxymethylcellulose Consumption., Cell Mol Gastroenterol Hepatol 2024 ; 17(2): 315-318.
• 2024
  Rives C, Martin CMP, Evariste L, Polizzi A, Huillet M, Lasserre F, Alquier-Bacquie V, Perrier P, Gomez J, Lippi Y, Naylies C, Levade T, Sabourdy F, Remignon H, Fafournoux P, Chassaing B, Loiseau N, Guillou H, Ellero-Simatos S, Gamet-Payrastre L, Fougerat A, Dietary Amino Acid Source Elicits Sex-Specific Metabolic Response to Diet-Induced NAFLD in Mice., Mol Nutr Food Res 2024 Jan; 68(1): e2300491.
• 2023
  Langhi C, Vallier M, Otero YF, Maura M, Le Joubioux F, Groult H, Achour O, Pebriana RB, Giera M, Guigas B, Maugard T, Chassaing B, Peltier S, Bard JM, Sirvent P, Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption., Nutrients 2023 Dec; 15(24): .
• 2023
  Ding X, Robbe-Masselot C, Fu X, Léonard R, Marsac B, Dauriat CJG, Lepissier A, Rytter H, Ramond E, Dupuis M, Euphrasie D, Dubail I, Schimmich C, Qin X, Parraga J, Leite-de-Moraes M, Ferroni A, Chassaing B, Sermet-Gaudelus I, Charbit A, Coureuil M, Jamet A, Airway environment drives the selection of quorum sensing mutants and promote Staphylococcus aureus chronic lifestyle., Nat Commun 2023 Dec; 14(1): 8135.
• 2023
  Fayfman M, Gewirtz AT, Delaroque C, Blanco G, Gibanica S, Srinivasan S, Chassaing B, Microbiome differences related to metformin intolerance among Black individuals with diabetes, a pilot cross-sectional study., Metabol Open 2023 Dec; 20(): 100256.
• 2023
  Harder HJ, Dauriat CJG, Chassaing B, Murphy AZ, Perinatal Morphine Exposure Induces Long-Term Changes in the Intestinal Microbiota of Male and Female Rats., bioRxiv 2023 Sep; (): .
• 2023
  Dopavogui L, Régnier M, Polizzi A, Ponchon Q, Smati S, Klement W, Lasserre F, Lukowicz C, Lippi Y, Fougerat A, Bertrand-Michel J, Naylies C, Canlet C, Debrauwer L, Rousseau-Bacquié E, Gamet-Payrastre L, Dauriat C, Casas J, Croubels S, De Baere S, Burger HM, Chassaing B, Ellero-Simatos S, Guillou H, Oswald IP, Loiseau N, Obesity promotes fumonisin B1 hepatotoxicity., Sci Total Environ 2023 Sep; 891(): 164436.
• 2023
  Sellem L, Srour B, Javaux G, Chazelas E, Chassaing B, Viennois E, Debras C, Salamé C, Druesne-Pecollo N, Esseddik Y, de Edelenyi FS, Agaësse C, De Sa A, Lutchia R, Louveau E, Huybrechts I, Pierre F, Coumoul X, Fezeu LK, Julia C, Kesse-Guyot E, Allès B, Galan P, Hercberg S, Deschasaux-Tanguy M, Touvier M, Food additive emulsifiers and risk of cardiovascular disease in the NutriNet-Santé cohort: prospective cohort study., BMJ 2023 Sep; 382(): e076058.
• 2023
  Kordahi MC, Delaroque C, Bredèche MF, Gewirtz AT, Chassaing B, Vaccination against microbiota motility protects mice from the detrimental impact of dietary emulsifier consumption., PLoS Biol 2023 Sep; 21(9): e3002289.
• 2023
  Pontarollo G, Kollar B, Mann A, Khuu MP, Kiouptsi K, Bayer F, Brandão I, Zinina VV, Hahlbrock J, Malinarich F, Mimmler M, Bhushan S, Marini F, Ruf W, Belheouane M, Baines JF, Endres K, Reba SM, Raker VK, Deppermann C, Welsch C, Bosmann M, Soshnikova N, Chassaing B, Bergentall M, Sommer F, Bäckhed F, Reinhardt C, Author Correction: Commensal bacteria weaken the intestinal barrier by suppressing epithelial neuropilin-1 and Hedgehog signaling., Nat Metab 2023 Sep; 5(9): 1639.
• 2023
  Maruyama D, Liao WI, Tian X, Bredon M, Knapp J, Tat C, Doan TNM, Chassaing B, Bhargava A, Sokol H, Prakash A, Regulation of Lung Immune Tone by the Gut-Lung Axis via Dietary Fiber, Gut Microbiota, and Short-Chain Fatty Acids., bioRxiv 2023 Aug; (): .
• 2023
  Evariste L, Lamas B, Ellero-Simatos S, Khoury L, Cartier C, Gaultier E, Chassaing B, Feltin N, Devoille L, Favre G, Audebert M, Houdeau E, A 90-day oral exposure to food-grade gold at relevant human doses impacts the gut microbiota and the local immune system in a sex-dependent manner in mice., Part Fibre Toxicol 2023 Jul; 20(1): 27.
• 2023
  Pontarollo G, Kollar B, Mann A, Khuu MP, Kiouptsi K, Bayer F, Brandão I, Zinina VV, Hahlbrock J, Malinarich F, Mimmler M, Bhushan S, Marini F, Ruf W, Belheouane M, Baines JF, Endres K, Reba SM, Raker VK, Deppermann C, Welsch C, Bosmann M, Soshnikova N, Chassaing B, Bergentall M, Sommer F, Bäckhed F, Reinhardt C, Commensal bacteria weaken the intestinal barrier by suppressing epithelial neuropilin-1 and Hedgehog signaling., Nat Metab 2023 Jul; 5(7): 1174-1187.
• 2023
  Daniel N, Gewirtz AT, Chassaing B, Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism., Gut 2023 May; 72(5): 906-917.
• 2023
  Denizot J, Chassaing B, Mirroring Amino Acids Hold Sway to Scare Pathobionts Away., Cell Mol Gastroenterol Hepatol 2023 ; 16(6): 1038-1039.
• 2023
  Daniel N, Le Barz M, Mitchell PL, Varin TV, Julien IB, Farabos D, Pilon G, Gauthier J, Garofalo C, Kang JX, Trottier J, Barbier O, Roy D, Chassaing B, Levy E, Raymond F, Lamaziere A, Flamand N, Silvestri C, Jobin C, Di Marzo V, Marette A, Comparing Transgenic Production to Supplementation of ω-3 PUFA Reveals Distinct But Overlapping Mechanisms Underlying Protection Against Metabolic and Hepatic Disorders., Function (Oxf) 2023 ; 4(2): zqac069.
• 2023
  Rytter H, Combet E, Chassaing B, Probiotic: is diet part of the efficacy equation?, Gut Microbes 2023 ; 15(1): 2222438.
• 2023
  Bretin A, Zou J, San Yeoh B, Ngo VL, Winer S, Winer DA, Reddivari L, Pellizzon M, Walters WA, Patterson AD, Ley R, Chassaing B, Vijay-Kumar M, Gewirtz AT, Psyllium Fiber Protects Against Colitis Via Activation of Bile Acid Sensor Farnesoid X Receptor., Cell Mol Gastroenterol Hepatol 2023 ; 15(6): 1421-1442.
• 2023
  Castillo-Ruiz A, Gars A, Sturgeon H, Ronczkowski NM, Pyaram DN, Dauriat CJG, Chassaing B, Forger NG, Brain effects of gestating germ-free persist in mouse neonates despite acquisition of a microbiota at birth., Front Neurosci 2023 ; 17(): 1130347.
• 2022
  Srour B, Kordahi MC, Bonazzi E, Deschasaux-Tanguy M, Touvier M, Chassaing B, Ultra-processed foods and human health: from epidemiological evidence to mechanistic insights., Lancet Gastroenterol Hepatol 2022 Dec; 7(12): 1128-1140.
• 2022
  Harusato A, Chassaing B, Dauriat CJG, Ushiroda C, Seo W, Itoh Y, Dietary Emulsifiers Exacerbate Food Allergy and Colonic Type 2 Immune Response through Microbiota Modulation., Nutrients 2022 Nov; 14(23): .
• 2022
  Chassaing B, When NOD ligands become antidotes., Cell Host Microbe 2022 Oct; 30(10): 1345-1346.
• 2022
  Chassaing B, Gewirtz AT, Lewis JD, Reply., Gastroenterology 2022 Sep; 163(3): 781-782.
• 2022
  Mallaret G, Lashermes A, Meleine M, Boudieu L, Barbier J, Aissouni Y, Gelot A, Chassaing B, Gewirtz AT, Ardid D, Carvalho FA, Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation., World J Gastroenterol 2022 Aug; 28(29): 3903-3916.
• 2022
  Hobson CA, Vigue L, Naimi S, Chassaing B, Magnan M, Bonacorsi S, Gachet B, El Meouche I, Birgy A, Tenaillon O, MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment., JAC Antimicrob Resist 2022 Aug; 4(4): dlac077.
• 2022
  Bizeau JB, Albouery M, Grégoire S, Buteau B, Martine L, Crépin M, Bron AM, Berdeaux O, Acar N, Chassaing B, Bringer MA, Dietary Inulin Supplementation Affects Specific Plasmalogen Species in the Brain., Nutrients 2022 Jul; 14(15): .
• 2022
  Torp AM, Kamguyan K, Christfort JF, Kristensen KA, Guerra P, Daniel N, Nielsen LH, Zòr K, Chassaing B, Boisen A, Bahl MI, Licht TR, Local Delivery of Streptomycin in Microcontainers Facilitates Colonization of Streptomycin-Resistant Escherichia coli in the Rat Colon., Appl Environ Microbiol 2022 Jul; 88(14): e0073422.
• 2022
  Arnold AR, Chassaing B, Pearce BD, Huhman KL, Dietary emulsifier consumption alters gene expression in the amygdala and paraventricular nucleus of the hypothalamus in mice., Sci Rep 2022 Jun; 12(1): 9146.
• 2022
  Plissonneau C, Sivignon A, Chassaing B, Capel F, Martin V, Etienne M, Wawrzyniak I, Chausse P, Dutheil F, Mairesse G, Chesneau G, Boisseau N, Barnich N, Beneficial Effects of Linseed Supplementation on Gut Mucosa-Associated Microbiota in a Physically Active Mouse Model of Crohn’s Disease., Int J Mol Sci 2022 May; 23(11): .
• 2022
  Fields CT, Chassaing B, de Vries GJ, Gut Barrier Dysfunction and Type 2 Immunity: Implications for Compulsive Behavior., Med Hypotheses 2022 Apr; 161(): .
• 2022
  Chassaing B, Compher C, Bonhomme B, Liu Q, Tian Y, Walters W, Nessel L, Delaroque C, Hao F, Gershuni V, Chau L, Ni J, Bewtra M, Albenberg L, Bretin A, McKeever L, Ley RE, Patterson AD, Wu GD, Gewirtz AT, Lewis JD, Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome., Gastroenterology 2022 Mar; 162(3): 743-756.
• 2022
  Dupuit M, Rance M, Morel C, Bouillon P, Boscaro A, Martin V, Vazeille E, Barnich N, Chassaing B, Boisseau N, Effect of Concurrent Training on Body Composition and Gut Microbiota in Postmenopausal Women with Overweight or Obesity., Med Sci Sports Exerc 2022 Mar; 54(3): 517-529.
• 2022
  Mills RH, Dulai PS, Vázquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, Batachari LE, Malfavon M, Zhu Q, Weldon K, Humphrey G, Carrillo-Terrazas M, Goldasich LD, Bryant M, Raffatellu M, Quinn RA, Gewirtz AT, Chassaing B, Chu H, Sandborn WJ, Dorrestein PC, Knight R, Gonzalez DJ, Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity., Nat Microbiol 2022 Feb; 7(2): 262-276.
• 2022
  Bonazzi E, Delaroque C, Chassaing B, [Food emulsifiers and intestinal microbiota: beware of your muffin!]., Med Sci (Paris) 2022 ; 38(6-7): 539-541.
• 2022
  Viennois E, Gewirtz AT, Chassaing B, Connecting the Dots: Dietary Fat, Microbiota Dysbiosis, Altered Metabolome, and Colon Cancer., Gastroenterology 2022 Jan; 162(1): 38-39.
• 2022
  Gonzalez CG, Mills RH, Kordahi MC, Carrillo-Terrazas M, Secaira-Morocho H, Widjaja CE, Tsai MS, Mittal Y, Yee BA, Vargas F, Weldon K, Gauglitz JM, Delaroque C, Sauceda C, Rossitto LA, Ackermann G, Humphrey G, Swafford AD, Siegel CA, Buckey JC, Raffals LE, Sadler C, Lindholm P, Fisch KM, Valaseck M, Suriawinata A, Yeo GW, Ghosh P, Chang JT, Chu H, Dorrestein P, Zhu Q, Chassaing B, Knight R, Gonzalez DJ, Dulai PS, The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients., Cell Mol Gastroenterol Hepatol 2022 ; 14(1): 35-53.
• 2022
  Delaroque C, Wu GD, Compher C, Ni J, Albenberg L, Liu Q, Tian Y, Patterson AD, Lewis JD, Gewirtz AT, Chassaing B, Diet standardization reduces intra-individual microbiome variation., Gut Microbes 2022 ; 14(1): 2149047.
• 2022
  Hobson CA, Vigué L, Magnan M, Chassaing B, Naimi S, Gachet B, Claraz P, Storme T, Bonacorsi S, Tenaillon O, Birgy A, A Microbiota-Dependent Response to Anticancer Treatment in an In Vitro Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin., Front Cell Infect Microbiol 2022 ; 12(): 886447.
• 2021
  Daniel N, Lécuyer E, Chassaing B, Host/microbiota interactions in health and diseases-Time for mucosal microbiology!, Mucosal Immunol 2021 Sep; 14(5): 1006-1016.
• 2021
  Lécuyer E, Le Roy T, Gestin A, Lacombe A, Philippe C, Ponnaiah M, Huré JB, Fradet M, Ichou F, Boudebbouze S, Huby T, Gautier E, Rhimi M, Maguin E, Kapel N, Gérard P, Venteclef N, Garlatti M, Chassaing B, Lesnik P, Tolerogenic Dendritic Cells Shape a Transmissible Gut Microbiota That Protects From Metabolic Diseases., Diabetes 2021 Sep; 70(9): 2067-2080.
• 2021
  Bancil AS, Sandall AM, Rossi M, Chassaing B, Lindsay JO, Whelan K, Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease., J Crohns Colitis 2021 Jun; 15(6): 1068-1079.
• 2021
  Daniel N, Rossi Perazza L, Varin TV, Trottier J, Marcotte B, St-Pierre P, Barbier O, Chassaing B, Marette A, Dietary fat and low fiber in purified diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments., Am J Physiol Gastrointest Liver Physiol 2021 Jun; 320(6): G1014-G1033.
• 2021
  Dupuit M, Chavanelle V, Chassaing B, Perriere F, Etienne M, Plissonneau C, Boscaro A, Barnich N, Pialoux V, Maugard T, Le Joubioux F, Peltier S, Sirvent P, Otero YF, Boisseau N, The TOTUM-63 Supplement and High-Intensity Interval Training Combination Limits Weight Gain, Improves Glycemic Control, and Influences the Composition of Gut Mucosa-Associated Bacteria in Rats on a High Fat Diet., Nutrients 2021 May; 13(5): .
• 2021
  Zou J, Zhao X, Shi Z, Zhang Z, Vijay-Kumar M, Chassaing B, Gewirtz AT, Critical Role of Innate Immunity to Flagellin in the Absence of Adaptive Immunity., J Infect Dis 2021 Apr; 223(8): 1478-1487.
• 2021
  Barnich N, Rodrigues M, Sauvanet P, Chevarin C, Denis S, Le Goff O, Faure-Imbert D, Hanh T, Roques CF, Chassaing B, Alric M, Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota., Int J Mol Sci 2021 Apr; 22(9): .
• 2021
  Albouery M, Bretin A, Buteau B, Grégoire S, Martine L, Gambert S, Bron AM, Acar N, Chassaing B, Bringer MA, Soluble Fiber Inulin Consumption Limits Alterations of the Gut Microbiota and Hepatic Fatty Acid Metabolism Caused by High-Fat Diet., Nutrients 2021 Mar; 13(3): .
• 2021
  Naimi S, Viennois E, Gewirtz AT, Chassaing B, Direct impact of commonly used dietary emulsifiers on human gut microbiota., Microbiome 2021 Mar; 9(1): 66.
• 2021
  Viennois E, Chassaing B, Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma., Int J Mol Sci 2021 Mar; 22(5): .
• 2021
  Plissonneau C, Capel F, Chassaing B, Dupuit M, Maillard F, Wawrzyniak I, Combaret L, Dutheil F, Etienne M, Mairesse G, Chesneau G, Barnich N, Boisseau N, High-Intensity Interval Training and α-Linolenic Acid Supplementation Improve DHA Conversion and Increase the Abundance of Gut Mucosa-Associated Oscillospira Bacteria., Nutrients 2021 Feb; 13(3): .
• 2021
  Partrick KA, Rosenhauer AM, Auger J, Arnold AR, Ronczkowski NM, Jackson LM, Lord MN, Abdulla SM, Chassaing B, Huhman KL, Ingestion of probiotic (Lactobacillus helveticus and Bifidobacterium longum) alters intestinal microbial structure and behavioral expression following social defeat stress., Sci Rep 2021 Feb; 11(1): 3763.
• 2021
  Kordahi MC, Chassaing B, The Intestinal Microbiota: Our Best Frenemy in Radiation-Induced Damages?, Cell Host Microbe 2021 Jan; 29(1): 7-9.
• 2021
  Barnich N, Chassaing B, When Pathobiont-Carbohydrate Interaction Turns Bittersweet!, Cell Mol Gastroenterol Hepatol 2021 ; 12(4): 1509-1510.
• 2021
  Delaroque C, Chervy M, Gewirtz AT, Chassaing B, Social overcrowding impacts gut microbiota, promoting stress, inflammation, and dysglycemia., Gut Microbes 2021 ; 13(1): 2000275.
• 2021
  Daoust L, Choi BS, Lacroix S, Rodrigues Vilela V, Varin TV, Dudonné S, Pilon G, Roy D, Levy E, Desjardins Y, Chassaing B, Marette A, The postnatal window is critical for the development of sex-specific metabolic and gut microbiota outcomes in offspring., Gut Microbes 2021 ; 13(1): 2004070.
• 2021
  Larsen IS, Jensen BAH, Bonazzi E, Choi BSY, Kristensen NN, Schmidt EGW, Süenderhauf A, Morin L, Olsen PB, Hansen LBS, Schröder T, Sina C, Chassaing B, Marette A, Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis., Gut Microbes 2021 ; 13(1): 1988836.
• 2021
  Zou J, Reddivari L, Shi Z, Li S, Wang Y, Bretin A, Ngo VL, Flythe M, Pellizzon M, Chassaing B, Gewirtz AT, Inulin Fermentable Fiber Ameliorates Type I Diabetes via IL22 and Short-Chain Fatty Acids in Experimental Models., Cell Mol Gastroenterol Hepatol 2021 ; 12(3): 983-1000.
• 2021
  Gars A, Ronczkowski NM, Chassaing B, Castillo-Ruiz A, Forger NG, First Encounters: Effects of the Microbiota on Neonatal Brain Development., Front Cell Neurosci 2021 ; 15(): 682505.
• 2020
  Viennois E, Bretin A, Dubé PE, Maue AC, Dauriat CJG, Barnich N, Gewirtz AT, Chassaing B, Dietary Emulsifiers Directly Impact Adherent-Invasive E. coli Gene Expression to Drive Chronic Intestinal Inflammation., Cell Rep 2020 Oct; 33(1): 108229.
• 2020
  Zhang Z, Zou J, Shi Z, Zhang B, Etienne-Mesmin L, Wang Y, Shi X, Shao F, Chassaing B, Gewirtz AT, IL-22-induced cell extrusion and IL-18-induced cell death prevent and cure rotavirus infection., Sci Immunol 2020 Oct; 5(52): .
• 2020
  Sandall AM, Cox SR, Lindsay JO, Gewirtz AT, Chassaing B, Rossi M, Whelan K, Emulsifiers Impact Colonic Length in Mice and Emulsifier Restriction is Feasible in People with Crohn’s Disease., Nutrients 2020 Sep; 12(9): .
• 2020
  Singh V, Galla S, Golonka RM, Patterson AD, Chassaing B, Joe B, Vijay-Kumar M, Lipocalin 2 deficiency-induced gut microbiota dysbiosis evokes metabolic syndrome in aged mice., Physiol Genomics 2020 Aug; 52(8): 314-321.
• 2020
  Viennois E, Pujada A, Sung J, Yang C, Gewirtz AT, Chassaing B, Merlin D, Impact of PepT1 deletion on microbiota composition and colitis requires multiple generations., NPJ Biofilms Microbiomes 2020 Jul; 6(1): 27.
• 2020
  Albouery M, Buteau B, Grégoire S, Martine L, Gambert S, Bron AM, Acar N, Chassaing B, Bringer MA, Impact of a high-fat diet on the fatty acid composition of the retina., Exp Eye Res 2020 Jul; 196(): 108059.
• 2020
  Defaye M, Nourrisson C, Baudu E, Lashermes A, Meynier M, Meleine M, Wawrzyniak I, Bonnin V, Barbier J, Chassaing B, Godfraind C, Gelot A, Barnich N, Ardid D, Bonnet M, Delbac F, Carvalho FA, Poirier P, Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats., Sci Rep 2020 Jun; 10(1): 9146.
• 2020
  Kuczma MP, Szurek EA, Cebula A, Chassaing B, Jung YJ, Kang SM, Fox JG, Stecher B, Ignatowicz L, Commensal epitopes drive differentiation of colonic Tregs., Sci Adv 2020 Apr; 6(16): eaaz3186.
• 2020
  Keita ÅV, Alkaissi LY, Holm EB, Heil SDS, Chassaing B, Darfeuille-Michaud A, McKay DM, Söderholm JD, Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn’s Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability., J Crohns Colitis 2020 Feb; 14(2): 216-229.
• 2020
  Mills RH, Wozniak JM, Vrbanac A, Campeau A, Chassaing B, Gewirtz A, Knight R, Gonzalez DJ, Organ-level protein networks as a reference for the host effects of the microbiome., Genome Res 2020 Feb; 30(2): 276-286.
• 2020
  Abo H, Chassaing B, Harusato A, Quiros M, Brazil JC, Ngo VL, Viennois E, Merlin D, Gewirtz AT, Nusrat A, Denning TL, Erythroid differentiation regulator-1 induced by microbiota in early life drives intestinal stem cell proliferation and regeneration., Nat Commun 2020 Jan; 11(1): 513.
• 2020
  Veziant J, Poirot K, Chevarin C, Cassagnes L, Sauvanet P, Chassaing B, Robin F, Godfraind C, Barnich N, Pezet D, Pereira B, Gagniere J, Bonnet M, Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)., BMJ Open 2020 Jan; 10(1): e031472.
• 2020
  Tran HQ, Bretin A, Adeshirlarijaney A, Yeoh BS, Vijay-Kumar M, Zou J, Denning TL, Chassaing B, Gewirtz AT, “Western Diet”-Induced Adipose Inflammation Requires a Complex Gut Microbiota., Cell Mol Gastroenterol Hepatol 2020 ; 9(2): 313-333.
• 2020
  Naimi S, Chassaing B, [Vaccination approach against chronic inflammatory diseases?]., Med Sci (Paris) 2020 ; 36(8-9): 689-691.
• 2020
  Daniel N, Chassaing B, The Hidden Effect of Nod2 in the Host/Microbiota Relationship., Cell Mol Gastroenterol Hepatol 2020 ; 10(2): 424-425.
• 2019
  Tran HQ, Ley RE, Gewirtz AT, Chassaing B, Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases., Nat Commun 2019 Dec; 10(1): 5650.
• 2019
  Adeshirlarijaney A, Zou J, Tran HQ, Chassaing B, Gewirtz AT, Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota., Am J Physiol Endocrinol Metab 2019 Dec; 317(6): E1121-E1130.
• 2019
  Le Roy T, Lécuyer E, Chassaing B, Rhimi M, Lhomme M, Boudebbouze S, Ichou F, Haro Barceló J, Huby T, Guerin M, Giral P, Maguin E, Kapel N, Gérard P, Clément K, Lesnik P, The intestinal microbiota regulates host cholesterol homeostasis., BMC Biol 2019 Nov; 17(1): 94.
• 2019
  Rolhion N, Chassaing B, Nahori MA, de Bodt J, Moura A, Lecuit M, Dussurget O, Bérard M, Marzorati M, Fehlner-Peach H, Littman DR, Gewirtz AT, Van de Wiele T, Cossart P, A Listeria monocytogenes Bacteriocin Can Target the Commensal Prevotella copri and Modulate Intestinal Infection., Cell Host Microbe 2019 Nov; 26(5): 691-701.e5.
• 2019
  Shi Z, Zou J, Zhang Z, Zhao X, Noriega J, Zhang B, Zhao C, Ingle H, Bittinger K, Mattei LM, Pruijssers AJ, Plemper RK, Nice TJ, Baldridge MT, Dermody TS, Chassaing B, Gewirtz AT, Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection., Cell 2019 Oct; 179(3): 644-658.e13.
• 2019
  Singh V, Yeoh BS, Walker RE, Xiao X, Saha P, Golonka RM, Cai J, Bretin ACA, Cheng X, Liu Q, Flythe MD, Chassaing B, Shearer GC, Patterson AD, Gewirtz AT, Vijay-Kumar M, Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation., Gut 2019 Oct; 68(10): 1801-1812.
• 2019
  Tran HQ, Mills RH, Peters NV, Holder MK, de Vries GJ, Knight R, Chassaing B, Gonzalez DJ, Gewirtz AT, Associations of the Fecal Microbial Proteome Composition and Proneness to Diet-induced Obesity., Mol Cell Proteomics 2019 Sep; 18(9): 1864-1879.
• 2019
  Etienne-Mesmin L, Chassaing B, Desvaux M, De Paepe K, Gresse R, Sauvaitre T, Forano E, de Wiele TV, Schüller S, Juge N, Blanquet-Diot S, Experimental models to study intestinal microbes-mucus interactions in health and disease., FEMS Microbiol Rev 2019 Sep; 43(5): 457-489.
• 2019
  Bretin A, Chassaing B, [Inulin: the beauty and the beast]., Med Sci (Paris) 2019 Feb; 35(2): 100-102.
• 2019
  Holder MK, Peters NV, Whylings J, Fields CT, Gewirtz AT, Chassaing B, de Vries GJ, Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner., Sci Rep 2019 Jan; 9(1): 172.
• 2019
  Viennois E, Gewirtz AT, Chassaing B, Chronic Inflammatory Diseases: Are We Ready for Microbiota-based Dietary Intervention?, Cell Mol Gastroenterol Hepatol 2019 ; 8(1): 61-71.
• 2019
  Viennois E, Chassaing B, Tahsin A, Pujada A, Wang L, Gewirtz AT, Merlin D, Host-derived fecal microRNAs can indicate gut microbiota healthiness and ability to induce inflammation., Theranostics 2019 ; 9(15): 4542-4557.
• 2019
  Chassaing B, Gewirtz AT, Identification of Inner Mucus-Associated Bacteria by Laser Capture Microdissection., Cell Mol Gastroenterol Hepatol 2019 ; 7(1): 157-160.
• 2019
  Arnold AR, Chassaing B, Maltodextrin, Modern Stressor of the Intestinal Environment., Cell Mol Gastroenterol Hepatol 2019 ; 7(2): 475-476.
• 2018
  Klurfeld DM, Davis CD, Karp RW, Allen-Vercoe E, Chang EB, Chassaing B, Fahey GC, Hamaker BR, Holscher HD, Lampe JW, Marette A, Martens E, O'Keefe SJ, Rose DJ, Saarela M, Schneeman BO, Slavin JL, Sonnenburg JL, Swanson KS, Wu GD, Lynch CJ, Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome., Am J Physiol Endocrinol Metab 2018 Dec; 315(6): E1087-E1097.
• 2018
  Fulde M, Sommer F, Chassaing B, van Vorst K, Dupont A, Hensel M, Basic M, Klopfleisch R, Rosenstiel P, Bleich A, Bäckhed F, Gewirtz AT, Hornef MW, Publisher Correction: Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition., Nature 2018 Nov; 563(7731): E25.
• 2018
  Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, Lapek JD, Zhang L, Wang WB, Hao S, Flythe MD, Gonzalez DJ, Cani PD, Conejo-Garcia JR, Xiong N, Kennett MJ, Joe B, Patterson AD, Gewirtz AT, Vijay-Kumar M, Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer., Cell 2018 Oct; 175(3): 679-694.e22.
• 2018
  Holder MK, Chassaing B, Impact of food additives on the gut-brain axis., Physiol Behav 2018 Aug; 192(): 173-176.
• 2018
  Fulde M, Sommer F, Chassaing B, van Vorst K, Dupont A, Hensel M, Basic M, Klopfleisch R, Rosenstiel P, Bleich A, Bäckhed F, Gewirtz AT, Hornef MW, Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition., Nature 2018 Aug; 560(7719): 489-493.
• 2018
  Etienne-Mesmin L, Chassaing B, Adekunle O, Mattei LM, Bushman FD, Gewirtz AT, Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile., Gut 2018 May; 67(5): 860-871.
• 2018
  Harusato A, Chassaing B, Insights on the impact of diet-mediated microbiota alterations on immunity and diseases., Am J Transplant 2018 Mar; 18(3): 550-555.
• 2018
  Viennois E, Chassaing B, First victim, later aggressor: How the intestinal microbiota drives the pro-inflammatory effects of dietary emulsifiers?, Gut Microbes 2018 Feb; 9(3): 1-4.
• 2018
  Zou J, Chassaing B, Singh V, Pellizzon M, Ricci M, Fythe MD, Kumar MV, Gewirtz AT, Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health., Cell Host Microbe 2018 Jan; 23(1): 41-53.e4.
• 2018
  Fields CT, Chassaing B, Paul MJ, Gewirtz AT, de Vries GJ, Vasopressin deletion is associated with sex-specific shifts in the gut microbiome., Gut Microbes 2018 Jan; 9(1): 13-25.
• 2018
  Chassaing B, Gewirtz AT, Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency., PLoS One 2018 ; 13(4): e0195310.
• 2018
  Kanhere M, Chassaing B, Gewirtz AT, Tangpricha V, Role of vitamin D on gut microbiota in cystic fibrosis., J Steroid Biochem Mol Biol 2018 Jan; 175(): 82-87.
• 2018
  Castillo-Ruiz A, Mosley M, George AJ, Mussaji LF, Fullerton EF, Ruszkowski EM, Jacobs AJ, Gewirtz AT, Chassaing B, Forger NG, The microbiota influences cell death and microglial colonization in the perinatal mouse brain., Brain Behav Immun 2018 Jan; 67(): 218-229.
• 2017
  Chassaing B, Vijay-Kumar M, Gewirtz AT, How diet can impact gut microbiota to promote or endanger health., Curr Opin Gastroenterol 2017 Nov; 33(6): 417-421.
• 2017
  Chassaing B, Raja SM, Lewis JD, Srinivasan S, Gewirtz AT, Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans., Cell Mol Gastroenterol Hepatol 2017 Sep; 4(2): 205-221.
• 2017
  Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT, Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation., Gut 2017 Aug; 66(8): 1414-1427.
• 2017
  Saha P, Chassaing B, Yeoh BS, Viennois E, Xiao X, Kennett MJ, Singh V, Vijay-Kumar M, Ectopic Expression of Innate Immune Protein, Lipocalin-2, in Lactococcus lactis Protects Against Gut and Environmental Stressors., Inflamm Bowel Dis 2017 Jul; 23(7): 1120-1132.
• 2017
  Miles JP, Zou J, Kumar MV, Pellizzon M, Ulman E, Ricci M, Gewirtz AT, Chassaing B, Supplementation of Low- and High-fat Diets with Fermentable Fiber Exacerbates Severity of DSS-induced Acute Colitis., Inflamm Bowel Dis 2017 Jul; 23(7): 1133-1143.
• 2017
  Etienne-Mesmin L, Chassaing B, Adekunle O, Mattei LM, Edwards AN, McBride SM, Bushman FD, Gewirtz AT, Genome Sequence of a Toxin-Positive Clostridium difficile Strain Isolated from Murine Feces., Genome Announc 2017 Apr; 5(14): .
• 2017
  Cordonnier C, Etienne-Mesmin L, Thévenot J, Rougeron A, Rénier S, Chassaing B, Darfeuille-Michaud A, Barnich N, Blanquet-Diot S, Livrelli V, Enterohemorrhagic Escherichia coli pathogenesis: role of Long polar fimbriae in Peyer’s patches interactions., Sci Rep 2017 Mar; 7(): 44655.
• 2017
  Reichardt F, Chassaing B, Nezami BG, Li G, Tabatabavakili S, Mwangi S, Uppal K, Liang B, Vijay-Kumar M, Jones D, Gewirtz AT, Srinivasan S, Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharide-induced TLR4 signalling., J Physiol 2017 Mar; 595(5): 1831-1846.
• 2017
  Etienne-Mesmin L, Chassaing B, Gewirtz AT, Tryptophan: A gut microbiota-derived metabolites regulating inflammation., World J Gastrointest Pharmacol Ther 2017 Feb; 8(1): 7-9.
• 2017
  Viennois E, Merlin D, Gewirtz AT, Chassaing B, Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis., Cancer Res 2017 Jan; 77(1): 27-40.
• 2016
  Nathalie Rolhion, Benoit Chassaing, When pathogenic bacteria meet the intestinal microbiota, Philosophical Transactions of the Royal Society B: Biological Sciences, 2016, 371 (1707), pp.1-9. ⟨10.1098/rstb.2015.0504⟩.
• 2016
  Floyd M, Winn M, Cullen C, Sil P, Chassaing B, Yoo DG, Gewirtz AT, Goldberg JB, McCarter LL, Rada B, Swimming Motility Mediates the Formation of Neutrophil Extracellular Traps Induced by Flagellated Pseudomonas aeruginosa., PLoS Pathog 2016 Nov; 12(11): e1005987.
• 2016
  Etienne-Mesmin L, Vijay-Kumar M, Gewirtz AT, Chassaing B, Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease., Cell Mol Gastroenterol Hepatol 2016 Sep; 2(5): 584-604.
• 2016
  Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT, Corrigendum: Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome., Nature 2016 Aug; 536(7615): 238.
• 2016
  Rios D, Wood MB, Li J, Chassaing B, Gewirtz AT, Williams IR, Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria., Mucosal Immunol 2016 Jul; 9(4): 907-16.
• 2016
  Singh V, Yeoh BS, Chassaing B, Zhang B, Saha P, Xiao X, Awasthi D, Shashidharamurthy R, Dikshit M, Gewirtz A, Vijay-Kumar M, Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis., Cell Mol Gastroenterol Hepatol 2016 Jul; 2(4): 482-498.e6.
• 2016
  Chassaing B, Microbiota Alterations in Inflammatory Bowel Diseases: From Correlation to Causality., Cell Mol Gastroenterol Hepatol 2016 Jul; 2(4): 403-404.
• 2016
  Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Adams J, Darby TM, Weitzmann MN, Mulle JG, Gewirtz AT, Jones RM, Pacifici R, Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics., J Clin Invest 2016 Jun; 126(6): 2049-63.
• 2016
  Anitha M, Reichardt F, Tabatabavakili S, Nezami BG, Chassaing B, Mwangi S, Vijay-Kumar M, Gewirtz A, Srinivasan S, Intestinal dysbiosis contributes to the delayed gastrointestinal transit in high-fat diet fed mice., Cell Mol Gastroenterol Hepatol 2016 May; 2(3): 328-339.
• 2016
  Geem D, Ngo V, Harusato A, Chassaing B, Gewirtz AT, Newberry RD, Denning TL, Contribution of Mesenteric Lymph Nodes and GALT to the Intestinal Foxp3+ Regulatory T-Cell Compartment., Cell Mol Gastroenterol Hepatol 2016 May; 2(3): 274-280.
• 2016
  Dollé L, Tran HQ, Etienne-Mesmin L, Chassaing B, Policing of gut microbiota by the adaptive immune system., BMC Med 2016 Feb; 14(): 27.
• 2016
  Chassaing B, Gewirtz AT, Has provoking microbiota aggression driven the obesity epidemic?, Bioessays 2016 Feb; 38(2): 122-8.
• 2016
  Medina-Contreras O, Harusato A, Nishio H, Flannigan KL, Ngo V, Leoni G, Neumann PA, Geem D, Lili LN, Ramadas RA, Chassaing B, Gewirtz AT, Kohlmeier JE, Parkos CA, Towne JE, Nusrat A, Denning TL, Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage., J Immunol 2016 Jan; 196(1): 34-8.
• 2016
  Vazeille E, Chassaing B, Buisson A, Dubois A, de Vallée A, Billard E, Neut C, Bommelaer G, Colombel JF, Barnich N, Darfeuille-Michaud A, Bringer MA, GipA Factor Supports Colonization of Peyer’s Patches by Crohn’s Disease-associated Escherichia Coli., Inflamm Bowel Dis 2016 Jan; 22(1): 68-81.
• 2015
  Singh V, Chassaing B, Zhang L, San Yeoh B, Xiao X, Kumar M, Baker MT, Cai J, Walker R, Borkowski K, Harvatine KJ, Singh N, Shearer GC, Ntambi JM, Joe B, Patterson AD, Gewirtz AT, Vijay-Kumar M, Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice., Cell Metab 2015 Dec; 22(6): 983-96.
• 2015
  Chassaing B, Miles-Brown J, Pellizzon M, Ulman E, Ricci M, Zhang L, Patterson AD, Vijay-Kumar M, Gewirtz AT, Lack of soluble fiber drives diet-induced adiposity in mice., Am J Physiol Gastrointest Liver Physiol 2015 Oct; 309(7): G528-41.
• 2015
  Etienne-Mesmin L, Wang T, Viennois E, Chassaing B, Gewirtz AT, Merlin D, Proceedings of the Second Shanthi V. Sitaraman Intestinal Pathobiology Symposium., Inflamm Bowel Dis 2015 Aug; 21(8): 1942-7.
• 2015
  Uchiyama R, Chassaing B, Zhang B, Gewirtz AT, MyD88-mediated TLR signaling protects against acute rotavirus infection while inflammasome cytokines direct Ab response., Innate Immun 2015 May; 21(4): 416-28.
• 2015
  Chassaing B, [The intestinal microbiota helps shapping the adaptive immune response against viruses]., Med Sci (Paris) 2015 Apr; 31(4): 355-7.
• 2015
  Chassaing B, Garénaux E, Carriere J, Rolhion N, Guérardel Y, Barnich N, Bonnet R, Darfeuille-Michaud A, Analysis of the σE regulon in Crohn’s disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation., J Bacteriol 2015 Apr; 197(8): 1451-65.
• 2015
  Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT, Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome., Nature 2015 Mar; 519(7541): 92-6.
• 2015
  Chassaing B, [Involvement of food additives in intestinal inflammation and metabolic syndrome in mice]., Med Sci (Paris) 2015 ; 31(6-7): 586-8.
• 2014
  Nicolas Auberger, Margherita Di Pisa, Maud Larregola, Gérard Chassaing, Elisa Peroni, Solange Lavielle, Anna-Maria Papini, Olivier Lequin, Jean-Maurice Mallet, Glaser oxidative coupling on peptides: Stabilization of β-turn structure via a 1,3-butadiyne constraint., Bioorganic and Medicinal Chemistry, 2014, 22 (24), pp.6924-6932. ⟨10.1016/j.bmc.2014.10.026⟩.
• 2014
  Leifer CA, McConkey C, Li S, Chassaing B, Gewirtz AT, Ley RE, Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome’s potential to cause inflammation., Immunol Lett 2014 Dec; 162(2 Pt A): 3-9.
• 2014
  Chassaing B, Ley RE, Gewirtz AT, Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice., Gastroenterology 2014 Dec; 147(6): 1363-77.e17.
• 2014
  Chassaing B, Gewirtz AT, Pathobiont hypnotises enterocytes to promote tumour development., Gut 2014 Dec; 63(12): 1837-8.
• 2014
  Zhang B, Chassaing B, Shi Z, Uchiyama R, Zhang Z, Denning TL, Crawford SE, Pruijssers AJ, Iskarpatyoti JA, Estes MK, Dermody TS, Ouyang W, Williams IR, Vijay-Kumar M, Gewirtz AT, Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18., Science 2014 Nov; 346(6211): 861-5.
• 2014
  Raisch J, Sivignon A, Chassaing B, Lapaquette P, Miquel S, Carvalho F, Rolhion N, Bringer MA, Barnich N, Boudeau J, Di Martino P, In Memoriam, Arlette Darfeuille-Michaud, PhD., Gastroenterology 2014 Nov; 147(5): 943-4.
• 2014
  Raisch J, Sivignon A, Chassaing B, Lapaquette P, Miquel S, Carvalho F, Rolhion N, Bringer MA, Barnich N, Boudeau J, Di Martino P, In Memoriam, Arlette Darfeuille-Michaud, PhD., Gut 2014 Nov; 63(11): 1681-2.
• 2014
  Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, Bower M, Hakimpour P, Gill KP, Nakaya HI, Yarovinsky F, Sartor RB, Gewirtz AT, Pulendran B, TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination., Immunity 2014 Sep; 41(3): 478-492.
• 2014
  Uchiyama R, Chassaing B, Zhang B, Gewirtz AT, Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity., J Infect Dis 2014 Jul; 210(2): 171-82.
• 2014
  Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT, AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition., Gut 2014 Jul; 63(7): 1069-80.
• 2014
  Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M, Dextran sulfate sodium (DSS)-induced colitis in mice., Curr Protoc Immunol 2014 Feb; 104(): 15.25.1-15.25.14.
• 2014
  Chassaing B, Gewirtz AT, Gut microbiota, low-grade inflammation, and metabolic syndrome., Toxicol Pathol 2014 Jan; 42(1): 49-53.
• 2014
  Chassaing B, Etienne-Mesmin L, Gewirtz AT, Microbiota-liver axis in hepatic disease., Hepatology 2014 Jan; 59(1): 328-39.
• 2014
  Chassaing B, Kumar M, Baker MT, Singh V, Vijay-Kumar M, Mammalian gut immunity., Biomed J 2014 ; 37(5): 246-58.
• 2013
  Cullender TC, Chassaing B, Janzon A, Kumar K, Muller CE, Werner JJ, Angenent LT, Bell ME, Hay AG, Peterson DA, Walter J, Vijay-Kumar M, Gewirtz AT, Ley RE, Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut., Cell Host Microbe 2013 Nov; 14(5): 571-81.
• 2013
  Shashidharamurthy R, Machiah D, Aitken JD, Putty K, Srinivasan G, Chassaing B, Parkos CA, Selvaraj P, Vijay-Kumar M, Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice., Arthritis Rheum 2013 Apr; 65(4): 1064-73.
• 2013
  Chassaing B, Etienne-Mesmin L, Bonnet R, Darfeuille-Michaud A, Bile salts induce long polar fimbriae expression favouring Crohn’s disease-associated adherent-invasive Escherichia coli interaction with Peyer’s patches., Environ Microbiol 2013 Feb; 15(2): 355-71.
• 2013
  Chassaing B, Darfeuille-Michaud A, The σE pathway is involved in biofilm formation by Crohn’s disease-associated adherent-invasive Escherichia coli., J Bacteriol 2013 Jan; 195(1): 76-84.
• 2012
  Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD, Su Y, Chassaing B, Walters WA, González A, Clemente JC, Cullender TC, Barnich N, Darfeuille-Michaud A, Vijay-Kumar M, Knight R, Ley RE, Gewirtz AT, Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice., Cell Host Microbe 2012 Aug; 12(2): 139-52.
• 2012
  Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, Borregaard N, Jones DP, Gewirtz AT, Vijay-Kumar M, Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis., J Immunol 2012 Aug; 189(4): 1911-9.
• 2012
  Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M, Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation., PLoS One 2012 ; 7(9): e44328.
• 2012
  Chassaing B, Aitken JD, Gewirtz AT, Vijay-Kumar M, Gut microbiota drives metabolic disease in immunologically altered mice., Adv Immunol 2012 ; 116(): 93-112.
• 2011
  Chassaing B, Darfeuille-Michaud A, The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases., Gastroenterology 2011 May; 140(6): 1720-28.
• 2011
  Chassaing B, Rolhion N, de Vallée A, Salim SY, Prorok-Hamon M, Neut C, Campbell BJ, Söderholm JD, Hugot JP, Colombel JF, Darfeuille-Michaud A, Crohn disease–associated adherent-invasive E. coli bacteria target mouse and human Peyer’s patches via long polar fimbriae., J Clin Invest 2011 Mar; 121(3): 966-75.
• 2011
  Chassaing B, Darfeuille-Michaud A, [The interaction of Crohn’s disease-associated Escherichia coli to Peyer’s patches of the intestinal mucosa involves long polar fimbriae]., Med Sci (Paris) 2011 ; 27(6-7): 572-3.
• 2011
  Etienne-Mesmin L, Chassaing B, Sauvanet P, Denizot J, Blanquet-Diot S, Darfeuille-Michaud A, Pradel N, Livrelli V, Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections., PLoS One 2011 ; 6(8): e23594.